Impact on survival of combination inhalers in patients with COPD at high risk of cardiovascular events

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease often co-exist and are both leading causes of death worldwide. Published data have previously suggested trends toward improved survival for patients taking long-acting β agonists combined with inhaled corticosteroids (LABA-ICS) through beneficial actions on the respiratory and cardiovascular systems. We sought to explore this in a real-world setting.

Source: International Journal of Cardiology - November 25, 2019 Category: Cardiology Authors: Hitesh C. Patel, Carl Hayward, Ketna Patel, Brian Claggett, Ali Vazir, Martin R. Cowie Source Type: research